# Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease

Study · id `cardio:ct-nct02504437` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02504437](<https://clinicaltrials.gov/study/NCT02504437>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02504437

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02504437. Randomized; double masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02504437, source copy `cardio:ctgov-nct02504437-2015-07-22`, retrieved 2026-10-26)
- Start date: 2015-11 (registry gives no type) (ClinicalTrials.gov record NCT02504437, source copy `cardio:ctgov-nct02504437-2015-07-22`, retrieved 2026-10-26)
- Primary completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02504437, source copy `cardio:ctgov-nct02504437-2015-07-22`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT02504437, source copy `cardio:ctgov-nct02504437-2015-07-22`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02504437-2015-07-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
- Acronym: TPAABPIHD
- Condition: Myocardial Infarction
- Condition: Acute Myocardial Infarction
- Condition: Ischemic Cardiomyopathy
- Intervention (Biological): BMMSCs
- Lead sponsor: Academy Military Medical Science, China
- Lead sponsor class: INDUSTRY
- Collaborator: Sun Yat-sen University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as a collaborator: Sun Yat-sen University (`cardio:org-sun-yat-sen-university`)

## Provenance

Content hash: fd93b4ff54f4819a6ef9c3622925b9d9f7137eef4fb4bb5af9a4834a6fbce625
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
